1. Pyridoxamine scavenges protein carbonyls and inhibits protein aggregation in oxidative stress-induced human HepG2 hepatocytes
- Author
-
Ryoko Ide, Kyozo Suyama, Mitsugu Akagawa, Kohei Dainin, and Ayumi Maeda
- Subjects
0301 basic medicine ,Transamination ,Protein Carbonylation ,Biophysics ,Protein aggregation ,medicine.disease_cause ,Biochemistry ,Antioxidants ,03 medical and health sciences ,chemistry.chemical_compound ,Protein Aggregates ,0302 clinical medicine ,medicine ,Humans ,Molecular Biology ,Pyridoxal ,chemistry.chemical_classification ,Reactive oxygen species ,Cell Biology ,Hep G2 Cells ,Hydrogen Peroxide ,Oxidative Stress ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,Muramidase ,Pyridoxamine ,Lysozyme ,Reactive Oxygen Species ,Oxidation-Reduction ,Oxidative stress - Abstract
Introduction of carbonyl groups into amino acid residues is a hallmark for oxidative damage to proteins by reactive oxygen species (ROS). Protein carbonylation can have deleterious effects on cell function and viability, since it is generally unrepairable by cells and can lead to protein dysfunction and to the production of potentially harmful protein aggregates. Meanwhile, pyridoxamine (PM) is known to scavenge various toxic carbonyl species derived from either glucose or lipid degradation through nucleophilic addition. PM is also demonstrated to catalyze non-enzymatic transamination reactions between amino and α-keto acids. Here, we found that PM scavenges protein carbonyls in oxidized BSA with concomitant generation of pyridoxal and recovers oxidized lysozyme activity. Moreover, we demonstrated that the treatment of H2O2-exposed HepG2 hepatocytes with PM significantly reduced levels of cellular carbonylated proteins and aggregated proteins, and also improved cell survival rate. Our results suggest that PM may have potential efficacy in ameliorating ROS-mediated cellular dysfunction.
- Published
- 2017